The image shows a hand holding a blue injection pen and pinching abdominal skin, illustrating obesity therapy, fat reduction and modern metabolic healthcare.
Retatrutide has demonstrated up to 24% body weight reduction in clinical research, while Zepbound has shown around 20% in similar settings
Development of Microbial Therapeutics for Metabolic-Associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials
HO-1, a critical antioxidant enzyme, enhances cellular defense against oxidative damage by catalyzing heme breakdown to produce Fe, carbon monoxide (CO), and biliverdin (35)
Neutrophil chemotaxis in acutely infected and clinically stable cystic fibrosis patients
Medically reviewed by Jessica Swirble, PharmD Last update: May 5, 2026 Est